AI-generated summary
The authors randomized 58 people with meibomian gland dysfunction to four weekly intense pulsed light sessions with either active or sham low-level light therapy. They report that adding active light therapy was associated with a greater increase in lipid layer thickness at 24 weeks, but no significant differences in symptoms, tear stability, staining or inflammatory markers.
- Participants
- 58
- Who or what was studied
- Adults with meibomian gland dysfunction grade 2 or higher
- Limits stated in the abstract
- The abstract reports no wavelength details and does not state whether the benefit to lipid layer thickness was clinically meaningful.
Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.
Abstract
The full abstract is not shown here because it is protected by the publisher’s copyright. Read it on linkinghub.elsevier.com.
Record from PubMed, a service of the National Library of Medicine.
How to read a trial: what to check before relying on this kind of research.
Terms in this paper: Low-level laser therapy, Sham, Primary outcome, GRADE. Each links to its definition in the glossary.
A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.